在肿瘤治疗中，相比于化疗药物，近年来生物制药日新月异，尤其是以单克隆抗体为代表的创新药已广泛应用于临床，比如大家耳熟能详的贝伐珠单抗，曲妥珠单抗，帕博利珠单抗等。由于大部分临床医生，不熟悉免疫基础知识，在学术交流中，单克隆抗体抗癌机制部分，令人费解的 ...

SE (NASDAQ:ARGX) said on Friday that it has received approval from the European Commission for its IgG Fc-antibody fragment, ...

This regulatory approval is the second for VYVGART SC in Europe, which first received approval as an add-on to standard therapy for the treatment of adult patients with generalized myasthenia gravis ...

Immune response to SARS-CoV-2: B-lymphocyte releases antibodies that bind to and mark coronaviruses. ... More Hence, the viruses can't penetrate into their target cells and are engulfed and ...

Incyte INCY announced that the FDA has approved its humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, ...

Creative Biolabs recently rolled out a three-dimensional upgrade designed to make antibodies safer, more potent, and easier to develop. SHIRLEY, NY, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- ...

Once hailed as the future of immuno-oncology, it’s been a tough few months for any remaining fans of anti-TIGIT antibodies. | ...

The global Fc and glycoengineered antibodies market is estimated to be worth US$ 38.8 billion in 2024 The new research study consists of industry trends, detailed Fc and glycoengineered antibodies ...

AGEN-1721 was designed as an Fc-enhanced bifunctional antibody to selectively target FAP and neutralize TGF-β via an optimized TGF-βR2 TRAP moiety fused to an engineered Fc region, with the aim of ...